Galenica Sante AG (GALE) - Net Assets

Latest as of December 2025: CHF1.49 Billion CHF ≈ $1.88 Billion USD

Based on the latest financial reports, Galenica Sante AG (GALE) has net assets worth CHF1.49 Billion CHF (≈ $1.88 Billion USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CHF3.34 Billion ≈ $4.23 Billion USD) and total liabilities (CHF1.86 Billion ≈ $2.35 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check GALE goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric Value
Current Net Assets CHF1.49 Billion
% of Total Assets 44.4%
Annual Growth Rate 17.26%
5-Year Change 20.37%
10-Year Change 344.34%
Growth Volatility 41.8

Galenica Sante AG - Net Assets Trend (2013–2025)

This chart illustrates how Galenica Sante AG's net assets have evolved over time, based on quarterly financial data. See GALE defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for Galenica Sante AG (2013–2025)

The table below shows the annual net assets of Galenica Sante AG from 2013 to 2025. For live valuation and market cap data, see GALE stock market capitalisation.

Year Net Assets Change
2025-12-31 CHF1.49 Billion
≈ $1.88 Billion		 -4.31%
2024-12-31 CHF1.55 Billion
≈ $1.96 Billion		 +5.20%
2023-12-31 CHF1.48 Billion
≈ $1.87 Billion		 +18.07%
2022-12-31 CHF1.25 Billion
≈ $1.58 Billion		 +1.28%
2021-12-31 CHF1.23 Billion
≈ $1.56 Billion		 +17.12%
2020-12-31 CHF1.05 Billion
≈ $1.33 Billion		 +5.38%
2019-12-31 CHF999.54 Million
≈ $1.26 Billion		 +7.06%
2018-12-31 CHF933.60 Million
≈ $1.18 Billion		 +8.37%
2017-12-31 CHF861.51 Million
≈ $1.09 Billion		 +157.78%
2016-12-31 CHF334.20 Million
≈ $422.53 Million		 +28.94%
2015-12-31 CHF259.19 Million
≈ $327.69 Million		 +7.88%
2014-12-31 CHF240.26 Million
≈ $303.76 Million		 +9.36%
2013-12-31 CHF219.71 Million
≈ $277.77 Million		 --

Equity Component Analysis

This analysis shows how different components contribute to Galenica Sante AG's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 611.4% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Retained Earnings CHF1.49 Billion 100.68%
Common Stock CHF5.00 Million 0.34%
Total Equity CHF1.48 Billion 100.00%

Galenica Sante AG Competitors by Market Cap

The table below lists competitors of Galenica Sante AG ranked by their market capitalization.

Company Market Cap
Narayana Hrudayalaya Ltd.
NSE:NH
 $4.09 Billion
MakeMyTrip Limited
NASDAQ:MMYT
 $4.09 Billion
Persimmon Plc
F:OHP
 $4.09 Billion
North Copper Shanxi Co Ltd
SHE:000737
 $4.10 Billion
Granite Real Estate Investment Trust
NYSE:GRTUF
 $4.09 Billion
PBF Energy Inc
NYSE:PBF
 $4.08 Billion
Steadfast Group Ltd
AU:SDF
 $4.08 Billion
Dun & Bradstreet Holdings Inc.
NYSE:DNB
 $4.08 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Galenica Sante AG's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 1,548,694,000 to 1,481,901,000, a change of -66,793,000 (-4.3%).
  • Net income of 181,099,000 contributed positively to equity growth.
  • Dividend payments of 115,113,000 reduced retained earnings.
  • Share repurchases of 14,008,000 reduced equity.
  • New share issuances of 6,043,000 increased equity.
  • Other factors decreased equity by 124,814,000.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income CHF181.10 Million +12.22%
Dividends Paid CHF115.11 Million -7.77%
Share Repurchases CHF14.01 Million -0.95%
Share Issuances CHF6.04 Million +0.41%
Other Changes CHF-124.81 Million -8.42%
Total Change CHF- -4.31%

Book Value vs Market Value Analysis

This analysis compares Galenica Sante AG's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 2.85x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has decreased from 18.36x to 2.85x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2014-12-31 CHF4.61 CHF84.55 x
2015-12-31 CHF5.08 CHF84.55 x
2016-12-31 CHF6.59 CHF84.55 x
2017-12-31 CHF17.47 CHF84.55 x
2018-12-31 CHF18.90 CHF84.55 x
2019-12-31 CHF20.13 CHF84.55 x
2020-12-31 CHF21.16 CHF84.55 x
2021-12-31 CHF24.73 CHF84.55 x
2022-12-31 CHF25.01 CHF84.55 x
2023-12-31 CHF29.49 CHF84.55 x
2024-12-31 CHF31.04 CHF84.55 x
2025-12-31 CHF29.71 CHF84.55 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Galenica Sante AG utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 12.22%
  • The company shows good efficiency in utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 4.38%
  • • Asset Turnover: 1.24x
  • • Equity Multiplier: 2.26x
  • Recent ROE (12.22%) is below the historical average (17.86%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2014 35.53% 2.90% 1.65x 7.42x CHF58.79 Million
2015 31.93% 2.78% 1.68x 6.82x CHF55.72 Million
2016 25.30% 2.77% 1.52x 6.02x CHF50.43 Million
2017 13.86% 3.78% 1.75x 2.10x CHF33.08 Million
2018 15.87% 4.65% 1.70x 2.00x CHF54.60 Million
2019 12.58% 3.78% 1.50x 2.22x CHF25.64 Million
2020 16.45% 4.95% 1.54x 2.16x CHF67.52 Million
2021 13.66% 4.37% 1.47x 2.13x CHF44.93 Million
2022 13.26% 4.11% 1.51x 2.14x CHF40.57 Million
2023 11.80% 4.63% 1.25x 2.03x CHF26.46 Million
2024 11.81% 4.67% 1.28x 1.98x CHF28.08 Million
2025 12.22% 4.38% 1.24x 2.26x CHF32.91 Million

Industry Comparison

This section compares Galenica Sante AG's net assets metrics with peer companies in the Medical Distribution industry.

No peer company data available for comparison.

About Galenica Sante AG

SW:GALE Switzerland Medical Distribution
Market Cap
$5.33 Billion
CHF4.21 Billion CHF
Market Cap Rank
#4136 Global
#60 in Switzerland
Share Price
CHF84.55
Change (1 day)
+0.54%
52-Week Range
CHF81.70 - CHF102.80
All Time High
CHF102.80
Categories
Companies in Switzerland Medical Distribution
About

Galenica AG provides healthcare services in Switzerland and internationally. It operates through two segments, Products & Care, and Logistics & IT. The Products & Care segment operates and manages pharmacies and partner pharmacies under the Amavita, Sun Store, and Coop Vitality brands, as well as covers specialty pharmacy mediservice. This segment also offers medication for treatment of patients … Read more